Literature DB >> 23256716

Managing comorbidity in COPD: a difficult task.

Ioanna G Tsiligianni1, Epameinondas Kosmas, Thys Van der Molen, Nikolaos Tzanakis.   

Abstract

Chronic obstructive pulmonary disease is a public health problem that results in high morbidity, disability and mortality. Comorbidities are highly prevalent in COPD patients because of aging, common risk factors and pathways, rising mortality, and disability. In this review article we present the most prevalent co-morbidities in COPD patients, we face the issue of multimorbidity and discuss the practical management approach relevant to chest physicians and general practitioners. Issues on comorbidities management according to general guidelines as well as their implications for COPD are raised. The aim is to give clinicians an easy update with specific recommendations for each comorbidity. The implications of several medications used for comorbidities in COPD in terms of benefits, concerns, medication preference, medication avoidance and contraindications are also discussed.

Entities:  

Mesh:

Year:  2013        PMID: 23256716     DOI: 10.2174/1389450111314020004

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  13 in total

1.  Multimorbidity and COPD Medication Receipt Among Medicaid Beneficiaries With Newly Diagnosed COPD.

Authors:  Mayank Ajmera; Usha Sambamoorthi; Aaron Metzger; Nilanjana Dwibedi; George Rust; Cindy Tworek
Journal:  Respir Care       Date:  2015-09-01       Impact factor: 2.258

Review 2.  Heterogeneity of chronic obstructive pulmonary disease: from phenotype to genotype.

Authors:  Xu Chen; Xiaomao Xu; Fei Xiao
Journal:  Front Med       Date:  2013-12       Impact factor: 4.592

3.  The complexity of managing COPD exacerbations: a grounded theory study of European general practice.

Authors:  Mette Bech Risør; Mark Spigt; R Iversen; M Godycki-Cwirko; N Francis; A Altiner; E Andreeva; K Kung; H Melbye
Journal:  BMJ Open       Date:  2013-12-05       Impact factor: 2.692

Review 4.  Managing comorbidities in COPD.

Authors:  Georgios Hillas; Fotis Perlikos; Ioanna Tsiligianni; Nikolaos Tzanakis
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-01-07

Review 5.  Epidemiology and clinical impact of major comorbidities in patients with COPD.

Authors:  Miranda Caroline Smith; Jeremy P Wrobel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-08-27

Review 6.  Acute exacerbation of COPD: is it the "stroke of the lungs"?

Authors:  Georgios Hillas; Fotis Perlikos; Nikolaos Tzanakis
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-07-13

7.  Frequency and risk factors of COPD exacerbations and hospitalizations: a nationwide study in Greece (Greek Obstructive Lung Disease Epidemiology and health ecoNomics: GOLDEN study).

Authors:  Evangelos C Alexopoulos; Foteini Malli; Eirini Mitsiki; Eleni G Bania; Christos Varounis; Konstantinos I Gourgoulianis
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-12-11

8.  Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease.

Authors:  Sheng-Hao Lin; Diahn-Warng Perng; Ching-Pei Chen; Woei-Horng Chai; Chin-Shui Yeh; Chew-Teng Kor; Shih-Lung Cheng; Jeremy Jw Chen; Ching-Hsiung Lin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-12-05

9.  Management of the COPD Patient with Comorbidities: An Experts Recommendation Document.

Authors:  Jesús Recio Iglesias; Jesús Díez-Manglano; Francisco López García; José Antonio Díaz Peromingo; Pere Almagro; José Manuel Varela Aguilar
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-05-07

10.  Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease.

Authors:  Gianna Camiciottoli; Francesca Bigazzi; Chiara Magni; Viola Bonti; Stefano Diciotti; Maurizio Bartolucci; Mario Mascalchi; Massimo Pistolesi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.